Distinct functions of junD in cardiac hypertrophy and heart failure

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Gene Regulation in Cardiac Hypertrophy

Background:

• Cardiac hypertrophy is a complex response to stress.
• Both adaptive and maladaptive pathways regulate cardiac growth.
• The roles of specific transcription factors like JunD and Fra-1 in these pathways require elucidation.

Purpose of the Study:

• To investigate the specific roles of JunD and Fra-1 in cardiac hypertrophy.
• To determine how these factors contribute to adaptive versus maladaptive cardiac growth.
• To explore the consequences of modulating JunD and Fra-1 expression in the heart.

Main Methods:

• Utilized genetically modified mouse models, including knockout and transgenic mice.
• Examined cardiac function and structure following mechanical pressure overload.
• Assessed cardiomyocyte apoptosis and mitochondrial function in transgenic models.

Main Results:

• Mice lacking JunD exhibited reduced adaptive hypertrophy under pressure overload.
• Overexpression of JunD in cardiomyocytes led to ventricular dilation and reduced contractility.
• Fra-1 conditional knockout mice showed normal hypertrophic response.
• Fra-1 transgenic mice displayed premature cardiac decompensation.
• Double knockout mice (Fra-1 transgenic, JunD lacking) developed dilated cardiomyopathy with apoptosis and mitochondrial defects.

Conclusions:

• JunD plays a dual role in cardiac hypertrophy, promoting both adaptive and maladaptive growth depending on expression levels.
• Fra-1 appears to contribute to maladaptive cardiac remodeling and decompensation.
• Combined genetic alterations in JunD and Fra-1 can lead to severe dilated cardiomyopathy.
• These findings highlight the critical roles of JunD and Fra-1 in cardiac health and disease.